Clinical cases of the treatment of metastatic colorectal cancer in Russia

Clinical cases of the treatment of metastatic colorectal cancer in Russia

The article presents the clinical cases of the targeted therapy regorafenib in metastatic colorectal cancer (mCRC) in Russia. Russian oncologists’ experience has not only confirmed the results of international clinical trials, but also clearly demonstrated the possibility of regorafenib long-term ad...

Full description

Bibliographic Details
Main Authors: V E Goldberg, A I Hasanova, V V Shkuratova, Yu V Belevich, N O Popova, E I Simolina, V V Vysockaya, E A Dudnikova, T L Kravchuk, R R Minnabetdinova, O V Nekrasova
Format: Article
Language:Russian
Published: IP Habib O.N. 2017-12-01
Series:Современная онкология
Subjects:
colorectal cancer (crc)
targeted therapy
regorafenib
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/27161/pdf
Description
Summary:The article presents the clinical cases of the targeted therapy regorafenib in metastatic colorectal cancer (mCRC) in Russia. Russian oncologists’ experience has not only confirmed the results of international clinical trials, but also clearly demonstrated the possibility of regorafenib long-term administration on the back of high efficacy and manageable safety profile.
ISSN:1815-1434
1815-1442

Similar Items